American Podiatric Surgeons’ Postoperative Multimodal Analgesic-Prescribing Practice: A 2019–2020 National Survey
Journal of the American Podiatric Medical Association · 2023
DOI: 10.7547/21-145 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Podiatric Medical Association, 2023. Verfasst von Brandon M Brooks und 5 weiteren Autor:innen. Beteiligte Einrichtung: *The Dartmouth Institute, Hanover, NH. Hauptthemen laut MEDLINE: Analgesics, Opioid, Surgeons. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Background
Surgery is a common setting for opioid-naive patients to first be exposed to opioids. Understanding the multimodal analgesic-prescribing habits of podiatric surgeons in the United States may be helpful to refining prescribing protocols. The purpose of this benchmark study was to identify whether certain demographic characteristics of podiatric surgeons were associated with their postoperative multimodal analgesic-prescribing practices.
Methods
We administered a scenario-based, voluntary, anonymous, online questionnaire that consisted of patient scenarios with a unique podiatric surgery followed by a demographics section. We developed multiple logistic regression models to identify associations between prescriber characteristics and the odds of supplementing with a nonsteroidal anti-inflammatory drug, regional nerve block, and anticonvulsant agent for each scenario. We developed multiple linear regression models to identify the association of multimodal analgesic-prescribing habits and the opioid dosage units prescribed at the time of surgery.
Results
Eight hundred sixty podiatric surgeons completed the survey. Years in practice was a statistically significant variable in multiple scenarios. Compared with those in practice for more than 15 years, podiatric surgeons in practice 5 years or less had increased odds of reporting supplementation with an anticonvulsant agent in scenarios 1 (odds ratio [OR], 2.4; 95% confidence interval [CI], 1.11–5.18; P = .03), 3 (OR, 2.97; 95% CI, 1.55–5.68; P = .001), 4 (OR, 2.54; 95% CI, 1.56–4.12; P < .001), and 5 (OR, 2.07; 95% CI, 1.29–3.32; P = .003).
Conclusions
Podiatric surgeons with fewer years in practice had increased odds of supplementing with an anticonvulsant. Approximately one-third of podiatric surgeons reported using some form of a nonopioid analgesic and an opioid in every scenario. The use of multimodal analgesics was associated with a reduction in the number of opioid dosage units prescribed at the time of surgery and may be a reasonable adjunct to current protocols.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- *The Dartmouth Institute, Hanover, NH.
- †Wm. Jennings Bryan Dorn VA Medical Center, Columbia, SC.
- ‡Dr. William M. Scholl College of Podiatric Medicine, North Chicago, IL.
- §University of South Alabama Health, Mobile, AL.
- ‖Stamford Health Medical Group, Darien, CT.
Zitieren
APA
Brooks, B. M., Bratches, R. W. R., Nettles, A. M., Fleischer, A. E., Brooks, B. M., & Albright, R. H. (2023). American Podiatric Surgeons’ Postoperative Multimodal Analgesic-Prescribing Practice: A 2019–2020 National Survey. Journal of the American Podiatric Medical Association. https://doi.org/10.7547/21-145
Vancouver
Brooks BM, Bratches RWR, Nettles AM, Fleischer AE, Brooks BM, Albright RH. American Podiatric Surgeons’ Postoperative Multimodal Analgesic-Prescribing Practice: A 2019–2020 National Survey. Journal of the American Podiatric Medical Association. 2023. doi:10.7547/21-145
BibTeX
@article{Brooks2023,
author = {Brooks, Brandon M and Bratches, Reed W R and Nettles, Ashley M and Fleischer, Adam E and Brooks, Bradley M and Albright, Rachel H},
title = {American Podiatric Surgeons’ Postoperative Multimodal Analgesic-Prescribing Practice: A 2019–2020 National Survey},
journal = {Journal of the American Podiatric Medical Association},
year = {2023},
doi = {10.7547/21-145}
}
EUVIMED